Cargando…
Developing a pan-cancer research autopsy programme
AIMS: Rapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre. METHODS: Advanced-stage...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817699/ https://www.ncbi.nlm.nih.gov/pubmed/31262953 http://dx.doi.org/10.1136/jclinpath-2019-205874 |
_version_ | 1783463478795698176 |
---|---|
author | Bavi, Prashant Siva, Madura Abi-Saab, Tarek Chadwick, Dianne Dhani, Neesha Butany, Jagdish Joshua, Anthony M Roehrl, Michael H |
author_facet | Bavi, Prashant Siva, Madura Abi-Saab, Tarek Chadwick, Dianne Dhani, Neesha Butany, Jagdish Joshua, Anthony M Roehrl, Michael H |
author_sort | Bavi, Prashant |
collection | PubMed |
description | AIMS: Rapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre. METHODS: Advanced-stage cancer patients, most commonly inpatients in palliative care facilities, were approached to participate in a cancer research autopsy programme with the goal of acquiring multidimensionally annotated tissue for cancer research. On death of an enrolled patient, a predetermined notification plan was enacted, with the medical oncologist/clinical research coordinator informing a team of pathologists, researchers and allied staff. Quality assurance metrics were measured. Thereafter, tissues were annotated in a tissue bioinformatics database and linked to electronic patient records. All banked tissues were reviewed for tumour integrity, including DNA and RNA quality. RESULTS: Over 100 rapid research autopsies from diverse cancer sites were performed, and specimens were procured and annotated with detailed clinical information, including treatment and response. Tissues were successfully enabling studies of tumour immunology, xenografts, genomics and proteomics. CONCLUSIONS: Large-scale rapid procurement and biobanking of cancer tissues from a rapid autopsy programme is feasible. Multidisciplinary integration between health and administrative staff from medical oncology, palliative care, pathology and biospecimen sciences is critical for the success of this challenging endeavour. |
format | Online Article Text |
id | pubmed-6817699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-68176992019-11-12 Developing a pan-cancer research autopsy programme Bavi, Prashant Siva, Madura Abi-Saab, Tarek Chadwick, Dianne Dhani, Neesha Butany, Jagdish Joshua, Anthony M Roehrl, Michael H J Clin Pathol Original Article AIMS: Rapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre. METHODS: Advanced-stage cancer patients, most commonly inpatients in palliative care facilities, were approached to participate in a cancer research autopsy programme with the goal of acquiring multidimensionally annotated tissue for cancer research. On death of an enrolled patient, a predetermined notification plan was enacted, with the medical oncologist/clinical research coordinator informing a team of pathologists, researchers and allied staff. Quality assurance metrics were measured. Thereafter, tissues were annotated in a tissue bioinformatics database and linked to electronic patient records. All banked tissues were reviewed for tumour integrity, including DNA and RNA quality. RESULTS: Over 100 rapid research autopsies from diverse cancer sites were performed, and specimens were procured and annotated with detailed clinical information, including treatment and response. Tissues were successfully enabling studies of tumour immunology, xenografts, genomics and proteomics. CONCLUSIONS: Large-scale rapid procurement and biobanking of cancer tissues from a rapid autopsy programme is feasible. Multidisciplinary integration between health and administrative staff from medical oncology, palliative care, pathology and biospecimen sciences is critical for the success of this challenging endeavour. BMJ Publishing Group 2019-10 2019-07-01 /pmc/articles/PMC6817699/ /pubmed/31262953 http://dx.doi.org/10.1136/jclinpath-2019-205874 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Article Bavi, Prashant Siva, Madura Abi-Saab, Tarek Chadwick, Dianne Dhani, Neesha Butany, Jagdish Joshua, Anthony M Roehrl, Michael H Developing a pan-cancer research autopsy programme |
title | Developing a pan-cancer research autopsy programme |
title_full | Developing a pan-cancer research autopsy programme |
title_fullStr | Developing a pan-cancer research autopsy programme |
title_full_unstemmed | Developing a pan-cancer research autopsy programme |
title_short | Developing a pan-cancer research autopsy programme |
title_sort | developing a pan-cancer research autopsy programme |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817699/ https://www.ncbi.nlm.nih.gov/pubmed/31262953 http://dx.doi.org/10.1136/jclinpath-2019-205874 |
work_keys_str_mv | AT baviprashant developingapancancerresearchautopsyprogramme AT sivamadura developingapancancerresearchautopsyprogramme AT abisaabtarek developingapancancerresearchautopsyprogramme AT chadwickdianne developingapancancerresearchautopsyprogramme AT dhanineesha developingapancancerresearchautopsyprogramme AT butanyjagdish developingapancancerresearchautopsyprogramme AT joshuaanthonym developingapancancerresearchautopsyprogramme AT roehrlmichaelh developingapancancerresearchautopsyprogramme |